Kambe T, Yamasaki T, Yamamoto A, Nagoshi A, et al. Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high-risk prostate cancer who underwent robot-assisted radical prostatectomy. Int J Urol 2024 Sep 10. doi: 10.1111/iju.15579.
PMID: 39253858